Amlin Plc
Subject: Amlin plc - 2004 Annual Results - Analysts' Meeting
-----------------
PRELIMINARY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2004 - DATE CHANGE
Amlin plc, the leading Lloyd's insurer, will now be announcing its annual
results for the year ended 31 December 2004 on Tuesday 8 March 2005 (previously
Thursday 10 March).
Other financial calendar dates for 2005 remain unchanged. The Annual General
Meeting is to be held on Wednesday 18 May and the interim results announced on
Monday 5 September.
The analysts' meeting will be held on Tuesday 8 March at Amlin's head office,
10th Floor, St Helen's, 1 Undershaft, London, EC3A 8ND. Coffee will be served at
9.45am for a prompt 10.00am start. Please register to attend by e-mailing
investor.relations@amlin.co.uk or by telephoning 020 7746 1074.
If you would prefer to take part in the conference call and/or webcast, please
let us know and we will provide 'dial-in' details nearer the time. Details of
the webcast arrangements will also be posted on Amlin's website at www.amlin.com
by no later than 7 days before the meeting.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.